PL308957A1 - Method of obtaining taxane derivatives, novel taxanes obtained thereby and composition containing suchtaxanes - Google Patents

Method of obtaining taxane derivatives, novel taxanes obtained thereby and composition containing suchtaxanes

Info

Publication number
PL308957A1
PL308957A1 PL93308957A PL30895793A PL308957A1 PL 308957 A1 PL308957 A1 PL 308957A1 PL 93308957 A PL93308957 A PL 93308957A PL 30895793 A PL30895793 A PL 30895793A PL 308957 A1 PL308957 A1 PL 308957A1
Authority
PL
Poland
Prior art keywords
suchtaxanes
composition containing
taxane derivatives
novel taxanes
obtaining
Prior art date
Application number
PL93308957A
Inventor
Jean-Dominique Bourzat
Alain Commercon
Dominique Deprez
Jean-Pierre Pulicani
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of PL308957A1 publication Critical patent/PL308957A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/20—Processes
    • C25B3/25—Reduction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B11/00—Electrodes; Manufacture thereof not otherwise provided for
    • C25B11/04—Electrodes; Manufacture thereof not otherwise provided for characterised by the material
    • C25B11/042—Electrodes formed of a single material
    • C25B11/046—Alloys
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B9/00—Cells or assemblies of cells; Constructional parts of cells; Assemblies of constructional parts, e.g. electrode-diaphragm assemblies; Process-related cell features
    • C25B9/17—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof
    • C25B9/19—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms
    • C25B9/23—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms comprising ion-exchange membranes in or on which electrode material is embedded

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Electrochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL93308957A 1992-11-12 1993-11-10 Method of obtaining taxane derivatives, novel taxanes obtained thereby and composition containing suchtaxanes PL308957A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9213586A FR2697841B1 (en) 1992-11-12 1992-11-12 New taxane derivatives, their preparation and the pharmaceutical compositions containing them.
PCT/FR1993/001102 WO1994011547A1 (en) 1992-11-12 1993-11-10 Process for the preparation of taxane derivatives, novel taxanes so obtained and antitumour and antileukaemia compositions containing same

Publications (1)

Publication Number Publication Date
PL308957A1 true PL308957A1 (en) 1995-09-04

Family

ID=9435452

Family Applications (1)

Application Number Title Priority Date Filing Date
PL93308957A PL308957A1 (en) 1992-11-12 1993-11-10 Method of obtaining taxane derivatives, novel taxanes obtained thereby and composition containing suchtaxanes

Country Status (15)

Country Link
EP (1) EP0667922A1 (en)
JP (1) JPH08503261A (en)
KR (1) KR950704540A (en)
AU (1) AU5425794A (en)
CA (1) CA2149240A1 (en)
CZ (1) CZ122495A3 (en)
FI (1) FI952294A7 (en)
FR (1) FR2697841B1 (en)
MX (1) MX9306883A (en)
NO (1) NO951772D0 (en)
PL (1) PL308957A1 (en)
RU (1) RU95112464A (en)
SK (1) SK60895A3 (en)
WO (1) WO1994011547A1 (en)
ZA (1) ZA938366B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
FR2710642B1 (en) * 1993-09-29 1995-11-17 Rhone Poulenc Rorer Sa New taxoids, their preparation and the pharmaceutical compositions containing them.
FR2711369B1 (en) * 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa New taxoids, their preparation and the compositions containing them.
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
WO1997044026A1 (en) * 1996-05-22 1997-11-27 Neuromedica, Inc. Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
ES2809302T3 (en) * 2004-01-22 2021-03-03 Univ Miami Coenzyme Q10 formulations to treat solid tumors by intravenous administration
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
AU2010247800A1 (en) 2009-05-11 2011-12-15 Berg Llc Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
CA2832324C (en) 2011-04-04 2022-03-15 Berg Llc Methods of treating central nervous system tumors
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
SG10201903112WA (en) 2013-04-08 2019-05-30 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
KR102370843B1 (en) 2013-09-04 2022-03-04 버그 엘엘씨 Methods of treatment of cancer by continuous infusion of coenzyme q10
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (en) * 1986-07-17 1988-09-23 Rhone Poulenc Sante TAXOL DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
FI952294A0 (en) 1995-05-11
MX9306883A (en) 1995-01-31
NO951772L (en) 1995-05-05
KR950704540A (en) 1995-11-20
FR2697841B1 (en) 1995-01-13
FI952294L (en) 1995-05-11
AU5425794A (en) 1994-06-08
CA2149240A1 (en) 1994-05-26
ZA938366B (en) 1994-06-13
FR2697841A1 (en) 1994-05-13
FI952294A7 (en) 1995-05-11
NO951772D0 (en) 1995-05-05
SK60895A3 (en) 1996-03-06
WO1994011547A1 (en) 1994-05-26
JPH08503261A (en) 1996-04-09
EP0667922A1 (en) 1995-08-23
CZ122495A3 (en) 1995-12-13
RU95112464A (en) 1997-02-20

Similar Documents

Publication Publication Date Title
PL308957A1 (en) Method of obtaining taxane derivatives, novel taxanes obtained thereby and composition containing suchtaxanes
AU5115393A (en) Novel derivatives of taxol analogues, preparation thereof and compositions containing them
PL309100A1 (en) Protamino insulin complex, pharmaceutical composition containing such complex and method of obtaining same as well as obtaining crystalline protamino insulin
PL327405A1 (en) Novel taxoids, method of obtaining them and pharmaceutic compositions containing such compounds
HUP0300836A3 (en) Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
AU9040491A (en) Method for the isolation and purification of taxane derivatives
GR900100688A (en) Novel macrocyclic compositions and new application method thereof
PL308361A1 (en) Novel taxane derivatives, method of obtaining them and pharmaceutical agents containing such derivatives
FI940075L (en) Process for the preparation of baccatin III and 10-desacetylbaccatin III derivatives
PL301281A1 (en) Novel organic compounds, method of obtaining such novel compounds and pharmaceutical composition containing them
FI952482A7 (en) New process for preparing taxane derivatives, derivatives thus obtained and compositions containing them
IL117486A0 (en) Oxazolidine derivatives and processes for the preparation of taxanes utilizing the same
PL298718A1 (en) Cyclic imine derivatives, therapeutic agents containing such compounds and method of obtaining them
KR950701629A (en) Novel taxane derivatives, their preparation and compositions containing same
PL321871A1 (en) Clavulanic salts and compositions containing them as well as method of obtaining such salts
JPS6480287A (en) Novel compound, method for manufacture of the same and drug composition containing the same
PL323447A1 (en) Novel compounds - derivatives of 4-hydroxypiperisine, method of obtaining them and drug containing such derivatives
HU9500578D0 (en) Novel poly-iodated compounds, method of preparation and contrast product containing same
ZA919224B (en) Process for preparing taxane derivatives,new derivatives obtained and pharmaceutical compositions containing them
ZA934741B (en) New derivatives of 10-deacetylbaccatin III, their preparation and pharmaceutical compositions containing them.
PL334144A1 (en) Novel derivatives of pyrolydine, composition containing and method of obtaining them
PL319070A1 (en) Derivatives of 1,25-dihydroxy-16,22,23-trisdehyrochoecalcifero, method of obtaining them and compositions containing such derivatives
PL304878A1 (en) Naphtoxasines, pharmaceutic composition containing them, application of naphtoxasines as pharmaceutic agents and method of obtaining them
HU9203660D0 (en) New nitrogen containing compounds, preparatives containing them and method to produce said compounds
ZA926828B (en) Novel alkoxy substituted taxanes and pharmaceutical compositions containing them.